Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim M Smits

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Clinical and Translational Gastroenterology|May 18, 2022
Lessons From a Systematic Literature Search on Diagnostic DNA Methylation Biomarkers for Colorectal Cancer: How to Increase Research Value and Decrease Research Waste?Zheng Feng, Cary J G Oberije, Alouisa J P van de Wetering, et al.
Oncology Letters|April 10, 2023
Histologic re‑evaluation of a population‑based series of renal cell carcinomas from The Netherlands Cohort Study according to the 2022 ISUP/WHO classificationSelena Odeh, Iryna V Samarska, Andres Matoso, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 18, 2024
Neuronal Distribution in Colorectal Cancer: Associations With Clinicopathological Parameters and SurvivalMaartje Massen, Meike S Thijssen, Glenn Rademakers, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 25, 2014
Spectrin repeat containing nuclear envelope 1 and forkhead box protein E1 are promising markers for the detection of colorectal cancer in bloodVeerle Melotte, Joo Mi Yi, Marjolein H F M Lentjes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2011
Genomic and epigenomic integration identifies a prognostic signature in colon cancerJoo Mi Yi, Mashaal Dhir, Leander Van Neste, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2016
PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancerJudith van Loon, Aniek J G Even, Hugo J W L Aerts, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 4, 2024
OTP, CD44, and Ki-67: A Prognostic Marker Panel for Relapse-Free Survival in Patients with Surgically Resected Pulmonary CarcinoidLaura Moonen, Jules L Derks, Michael A den Bakker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
A Four-Gene Promoter Methylation Marker Panel Consisting of <i>GREM1, NEURL, LAD1,</i> and <i>NEFH</i> Predicts Survival of Clear Cell Renal Cell Cancer PatientsIris J H van Vlodrop, Sophie C Joosten, Tim De Meyer, et al.
The Journal of Investigative Dermatology|August 1, 2025
Comprehensive Analysis of the Melanoma DNA Methylome Identifies LY75 Methylation as an Independent Marker Predicting Poor Clinical OutcomeKarin van den Hurk, Kim Lommen, Louis Coussement, et al.
Molecular Oncology|February 25, 2014
Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patientsMuriel X G Draht, Kim M Smits, Benjamin Tournier, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Clinical and Translational Gastroenterology|May 18, 2022
Lessons From a Systematic Literature Search on Diagnostic DNA Methylation Biomarkers for Colorectal Cancer: How to Increase Research Value and Decrease Research Waste?Zheng Feng, Cary J G Oberije, Alouisa J P van de Wetering, et al.
Oncology Letters|April 10, 2023
Histologic re‑evaluation of a population‑based series of renal cell carcinomas from The Netherlands Cohort Study according to the 2022 ISUP/WHO classificationSelena Odeh, Iryna V Samarska, Andres Matoso, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 18, 2024
Neuronal Distribution in Colorectal Cancer: Associations With Clinicopathological Parameters and SurvivalMaartje Massen, Meike S Thijssen, Glenn Rademakers, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 25, 2014
Spectrin repeat containing nuclear envelope 1 and forkhead box protein E1 are promising markers for the detection of colorectal cancer in bloodVeerle Melotte, Joo Mi Yi, Marjolein H F M Lentjes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2011
Genomic and epigenomic integration identifies a prognostic signature in colon cancerJoo Mi Yi, Mashaal Dhir, Leander Van Neste, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2016
PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancerJudith van Loon, Aniek J G Even, Hugo J W L Aerts, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 4, 2024
OTP, CD44, and Ki-67: A Prognostic Marker Panel for Relapse-Free Survival in Patients with Surgically Resected Pulmonary CarcinoidLaura Moonen, Jules L Derks, Michael A den Bakker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
A Four-Gene Promoter Methylation Marker Panel Consisting of <i>GREM1, NEURL, LAD1,</i> and <i>NEFH</i> Predicts Survival of Clear Cell Renal Cell Cancer PatientsIris J H van Vlodrop, Sophie C Joosten, Tim De Meyer, et al.
The Journal of Investigative Dermatology|August 1, 2025
Comprehensive Analysis of the Melanoma DNA Methylome Identifies LY75 Methylation as an Independent Marker Predicting Poor Clinical OutcomeKarin van den Hurk, Kim Lommen, Louis Coussement, et al.
Molecular Oncology|February 25, 2014
Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patientsMuriel X G Draht, Kim M Smits, Benjamin Tournier, et al.
Pageof 7